Clinical Trial Update: Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab plus irinotecan in colorectal cancer patients who progressed after prior cetuximab/irinotecan therapy; the study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• ERBITUX (cetuximab)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-05-16